SBIR
- Small Business Innovation Research
On this page:
Summary
The SBIR program is a set-aside program designed to support
innovative research conducted by small business concerns
to foster research on pharmaceuticals, medical devices
and implants, biologics, informatics, and biotechnologies
for the causes, prevention, diagnosis, and treatment of
heart, blood vessel, lung, and blood diseases. Innovation
and the potential for commercialization are among the important
factors included in the review criteria used in the scientific
and technical merit evaluation process. Additional information
on SBIRs can be found at http://grants.nih.gov/grants/funding/sbir.htm or NHLBI
SBIR site.
Eligibility
The SBIR Program includes small businesses participation
in Federal R/R&D to foster and encourage participation
by socially and economically disadvantaged small business
concerns and women-owned business concerns. The Principal
Investigator must
have his/her primary employment with the small business
concern at the time of award and for the duration of the
project period.
Scope of Support
Phase I. The objective of Phase I is
to establish the technical merit and feasibility of the
proposed R/R&D efforts and to determine the quality
of performance of the small business awardee organization
prior to providing further Federal support in Phase II.
Support under Phase I ($100,000) is normally provided for
six months.
Phase II. The objective of Phase
II is to continue the R/R&D efforts initiated in Phase
I. Only Phase I awardees are eligible for a Phase II award.
SBIR Phase II awards normally may not exceed $750,000 total.
However, applicants may propose longer periods of time
and greater amounts of funds necessary for completion of
the project.
How to Apply
Detailed information on application procedures is available
at http://grants.nih.gov/grants/funding/sbir.htm
When to Apply
Receipt dates for SBIR applications:
- April 5
- August 5
- December 5
|
